C&EN’s 2018 10 Start-Ups to Watch

Synthetic DNA is in high demand and current chemical synthesis methods cannot keep up with applications. Molecular Assemblies aims to fill the gap by commercializing the first fully enzymatic DNA synthesis technology.

“We’re looking for longer oligonucleotides or modified oligonucleotides that are difficult, if not impossible, for the phosphoramidite chemistry.” – J. William Efcavitch, Ph.D., cofounder and CSO of Molecular Assemblies

Read the full article here. Subscription may be required.